The Tübingen-based biotech company Curevac sees its patents being infringed by competitor Biontech’s corona vaccine, which has sold millions of times. Curevac has therefore filed a lawsuit against Biontech and two subsidiaries at the Düsseldorf Regional Court, the Tübingen-based company announced. Curevac is therefore demanding “fair compensation” for the violation of a number of its intellectual property rights that were used in the manufacture and sale of the Covid 19 vaccine by Biontech and its US partner Pfizer. However, the company emphasized that it was not planning any legal action that could hinder the production, sale or distribution of the vaccine.
Corona vaccine – Curevac sues Biontech – Economy
